• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中脑儿茶酚胺能神经元在进行性核上性麻痹中共同表达α-突触核蛋白和tau。

Midbrain catecholaminergic neurons co-express α-synuclein and tau in progressive supranuclear palsy.

机构信息

Department of Neurology, Complejo Hospitalario de Navarra Pamplona, Spain ; Instituto de Investigación Sanitaria de Navarra (IDISNA) Pamplona, Spain.

Instituto de Investigación Sanitaria de Navarra (IDISNA) Pamplona, Spain ; Brain Bank, Navarra Biomed Pamplona, Spain.

出版信息

Front Neuroanat. 2015 Mar 11;9:25. doi: 10.3389/fnana.2015.00025. eCollection 2015.

DOI:10.3389/fnana.2015.00025
PMID:25814937
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4356077/
Abstract

OBJECTIVE

To analyze the frequency and distribution of α-synuclein deposits in progressive supranuclear palsy (PSP).

METHODS

The brains of 25 cases of pathologically confirmed PSP were evaluated with immunohistochemistry for α-synuclein and tau. Multiple immunofluorescent stains were applied to analyze the expression of tau and α-synuclein aggregates in catecholaminergic neurons. Patients' clinical symptoms were retrospectively recorded.

RESULTS

Deposits α-synuclein in the form of typical Lewy bodies (LBs) were only found in two PSP cases (8%) that fulfilled the clinical subtype of PSP known as Richardson's syndrome (RS). LBs were present in the locus ceruleus (LC), substantia nigra pars compacta (SNc), basal forebrain, amygdala and cingulated cortex in a distribution mimicking that of Parkinson's disease (PD). Triple-immunolabeling revealed co-expression of α-synuclein and tau proteins in some tyrosine hydroxilase (TH)-positive neurons of the LC and SNc.

CONCLUSIONS

There is no apparent clinical correlation between the presence of LBs in PSP. Tau protein co-aggregate with α-synuclein in catecholaminergic neurons of PSP brains suggesting a synergistic interaction between the two proteins. This is in keeping with the current view of neurodegenerative disorders as "misfolded protein diseases".

摘要

目的

分析帕金森病相关核团路易小体(Lewy bodies,LB)在进行性核上性麻痹(progressive supranuclear palsy,PSP)中的分布频率。

方法

对 25 例经病理证实的 PSP 患者的脑组织进行α-突触核蛋白和 tau 的免疫组织化学分析。应用多重免疫荧光染色分析儿茶酚胺能神经元中 tau 和α-突触核蛋白聚集物的表达。回顾性记录患者的临床症状。

结果

只有在符合 Richardson 综合征(RS)临床亚型的 2 例 PSP 患者(8%)中发现了以典型路易小体(LB)形式存在的α-突触核蛋白沉积。LB 存在于蓝斑(LC)、黑质致密部(SNc)、基底前脑、杏仁核和扣带回皮质,分布类似于帕金森病(PD)。三重免疫标记显示 LC 和 SNc 中的一些酪氨酸羟化酶(TH)阳性神经元中存在α-突触核蛋白和 tau 蛋白的共表达。

结论

在 PSP 中 LB 的存在与临床无明显相关性。tau 蛋白与 PSP 脑中的α-突触核蛋白共聚集,提示这两种蛋白之间存在协同作用。这与神经退行性疾病是“错误折叠蛋白疾病”的观点一致。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a1c/4356077/6ac11f99e395/fnana-09-00025-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a1c/4356077/c2904793758d/fnana-09-00025-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a1c/4356077/7aa112a86333/fnana-09-00025-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a1c/4356077/6ac11f99e395/fnana-09-00025-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a1c/4356077/c2904793758d/fnana-09-00025-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a1c/4356077/7aa112a86333/fnana-09-00025-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a1c/4356077/6ac11f99e395/fnana-09-00025-g0003.jpg

相似文献

1
Midbrain catecholaminergic neurons co-express α-synuclein and tau in progressive supranuclear palsy.中脑儿茶酚胺能神经元在进行性核上性麻痹中共同表达α-突触核蛋白和tau。
Front Neuroanat. 2015 Mar 11;9:25. doi: 10.3389/fnana.2015.00025. eCollection 2015.
2
Lewy bodies in progressive supranuclear palsy represent an independent disease process.进行性核上性麻痹中的路易小体代表一种独立的疾病过程。
J Neuropathol Exp Neurol. 2006 Apr;65(4):387-95. doi: 10.1097/01.jnen.0000218449.17073.43.
3
Different tau pathology pattern in two clinical phenotypes of progressive supranuclear palsy.进行性核上性麻痹两种临床表型中的不同tau蛋白病理模式。
Neurodegener Dis. 2008;5(6):339-46. doi: 10.1159/000121388. Epub 2008 Mar 18.
4
Lewy bodies are not increased in progressive supranuclear palsy compared with normal controls.与正常对照组相比,进行性核上性麻痹患者的路易小体并未增多。
Neurology. 2001 Nov 13;57(9):1675-8. doi: 10.1212/wnl.57.9.1675.
5
Lewy bodies in progressive supranuclear palsy.进行性核上性麻痹中的路易小体。
Acta Neuropathol. 2002 Sep;104(3):273-8. doi: 10.1007/s00401-002-0555-3. Epub 2002 May 4.
6
Oligomeric α-synuclein and tau aggregates in NDEVs differentiate Parkinson's disease from atypical parkinsonisms.寡聚 α-突触核蛋白和 tau 聚集物在 NDEVs 中区分帕金森病与非典型帕金森病。
Neurobiol Dis. 2023 Jan;176:105947. doi: 10.1016/j.nbd.2022.105947. Epub 2022 Dec 5.
7
Tau pathology in the olfactory bulb correlates with Braak stage, Lewy body pathology and apolipoprotein epsilon4.嗅球中的tau病理与Braak分期、路易体病理和载脂蛋白ε4相关。
Neuropathol Appl Neurobiol. 2003 Oct;29(5):503-10. doi: 10.1046/j.1365-2990.2003.00453.x.
8
Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.脑内 α-突触核蛋白在多系统萎缩、帕金森病和进行性核上性麻痹中的蓄积:一项比较性研究。
Brain. 2010 Jan;133(Pt 1):172-88. doi: 10.1093/brain/awp282. Epub 2009 Nov 10.
9
[Clinical and pathological study on early diagnosis of Parkinson's disease and dementia with Lewy bodies].帕金森病与路易体痴呆早期诊断的临床与病理研究
Rinsho Shinkeigaku. 2008 Jan;48(1):11-24. doi: 10.5692/clinicalneurol.48.11.
10
Active, phosphorylation-dependent mitogen-activated protein kinase (MAPK/ERK), stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK), and p38 kinase expression in Parkinson's disease and Dementia with Lewy bodies.帕金森病和路易体痴呆中活性磷酸化依赖性丝裂原活化蛋白激酶(MAPK/ERK)、应激激活蛋白激酶/c-Jun氨基末端激酶(SAPK/JNK)和p38激酶的表达
J Neural Transm (Vienna). 2001;108(12):1383-96. doi: 10.1007/s007020100015.

引用本文的文献

1
CAS-SFCM: Content-Aware Image Smoothing Based on Fuzzy Clustering with Spatial Information.CAS-SFCM:基于带空间信息的模糊聚类的内容感知图像平滑
J Imaging. 2025 May 22;11(6):173. doi: 10.3390/jimaging11060173.
2
Progressive Supranuclear Palsy Syndrome: An Overview.进行性核上性麻痹综合征概述
IBRO Neurosci Rep. 2024 May 6;16:598-608. doi: 10.1016/j.ibneur.2024.04.008. eCollection 2024 Jun.
3
Progressive cognitive impairment and familial spastic paraparesis due to PRESENILIN 1 mutation: anatomoclinical characterization.

本文引用的文献

1
Interactions between Tau and α-synuclein augment neurotoxicity in a Drosophila model of Parkinson's disease.在帕金森病果蝇模型中,Tau与α-突触核蛋白之间的相互作用增强了神经毒性。
Hum Mol Genet. 2014 Jun 1;23(11):3008-23. doi: 10.1093/hmg/ddu011. Epub 2014 Jan 14.
2
Role of protein misfolding and proteostasis deficiency in protein misfolding diseases and aging.蛋白质错误折叠和蛋白质稳态缺陷在蛋白质错误折叠疾病及衰老中的作用。
Int J Cell Biol. 2013;2013:638083. doi: 10.1155/2013/638083. Epub 2013 Nov 17.
3
Cross-seeding of misfolded proteins: implications for etiology and pathogenesis of protein misfolding diseases.
早老素 1 突变所致进行性认知障碍和家族性痉挛性截瘫:解剖临床特征。
J Neurol. 2022 Sep;269(9):4853-4862. doi: 10.1007/s00415-022-11125-8. Epub 2022 Apr 19.
4
Glucocerebrosidase expression patterns in the non-human primate brain.非人类灵长类动物大脑中的葡萄糖脑苷脂酶表达模式。
Brain Struct Funct. 2018 Jan;223(1):343-355. doi: 10.1007/s00429-017-1504-1. Epub 2017 Aug 23.
5
A Preliminary Study on Investigation of Serum α-Synuclein and Tau Protein Levels in Children with Attention Deficit Hyperactivity Disorder.注意缺陷多动障碍患儿血清α-突触核蛋白和 Tau 蛋白水平检测的初步研究
Indian J Clin Biochem. 2017 Jul;32(3):285-291. doi: 10.1007/s12291-016-0602-9. Epub 2016 Aug 3.
6
Overlapping but distinct TDP-43 and tau pathologic patterns in aged hippocampi.老年海马体中重叠但不同的 TDP-43 和 tau 病理模式。
Brain Pathol. 2018 Mar;28(2):264-273. doi: 10.1111/bpa.12505. Epub 2017 Mar 24.
7
Editorial: Parkinson's disease: cell vulnerability and disease progression.社论:帕金森病:细胞易损性与疾病进展
Front Neuroanat. 2015 Sep 15;9:125. doi: 10.3389/fnana.2015.00125. eCollection 2015.
错误折叠蛋白的交叉播种:对蛋白质错误折叠疾病病因和发病机制的影响。
PLoS Pathog. 2013 Sep;9(9):e1003537. doi: 10.1371/journal.ppat.1003537. Epub 2013 Sep 19.
4
Visual hallucinations in the differential diagnosis of parkinsonism.视觉幻觉在帕金森病鉴别诊断中的作用。
J Neurol Neurosurg Psychiatry. 2012 Apr;83(4):448-52. doi: 10.1136/jnnp-2011-300980. Epub 2012 Jan 6.
5
Co-existence of Parkinson's disease and progressive supranuclear palsy: case report and a review of the literature.帕金森病与进行性核上性麻痹共存:病例报告及文献复习。
Neurol Sci. 2011 Feb;32(1):159-63. doi: 10.1007/s10072-010-0386-2. Epub 2010 Aug 25.
6
Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.脑内 α-突触核蛋白在多系统萎缩、帕金森病和进行性核上性麻痹中的蓄积:一项比较性研究。
Brain. 2010 Jan;133(Pt 1):172-88. doi: 10.1093/brain/awp282. Epub 2009 Nov 10.
7
Parkinsonism, dysautonomia, REM behaviour disorder and visual hallucinations mimicking synucleinopathy in a patient with progressive supranuclear palsy.一名进行性核上性麻痹患者出现帕金森综合征、自主神经功能障碍、快速眼动睡眠行为障碍以及类似突触核蛋白病的视幻觉。
J Neurol Neurosurg Psychiatry. 2009 May;80(5):578-9. doi: 10.1136/jnnp.2007.142810.
8
Progressive supranuclear palsy: a review of co-existing neurodegeneration.进行性核上性麻痹:并存神经退行性变的综述
Can J Neurol Sci. 2008 Nov;35(5):602-8. doi: 10.1017/s0317167100009392.
9
Co-localization of tau and alpha-synuclein in the olfactory bulb in Alzheimer's disease with amygdala Lewy bodies.在伴有杏仁核路易小体的阿尔茨海默病患者的嗅球中tau蛋白与α-突触核蛋白的共定位。
Acta Neuropathol. 2008 Jul;116(1):17-24. doi: 10.1007/s00401-008-0383-1. Epub 2008 Apr 30.
10
Management of a twenty-first century brain bank: experience in the BrainNet Europe consortium.21世纪脑库的管理:欧洲脑网联盟的经验
Acta Neuropathol. 2008 May;115(5):497-507. doi: 10.1007/s00401-008-0360-8. Epub 2008 Mar 26.